Childhood Lymphoma — Trials

Childhood Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

98 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 13
Recruiting: 6
Ph III recruiting: 1
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03478462	Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas(CLOVER-2)	active not recruiting	Phase 1	30	Cellectar Biosciences, Inc.INDUSTRY	3	Mar 18, 2026	clinicaltrials
NCT03817320	PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma	active not recruiting	Phase 1 / Phase 2	24	Therapeutic Advances in Childhood Leukemia ConsortiumOTHER